Page 2 - Diagnostics Accelerator News Today

Chancellor Jeremy Hunt announced the Innovation Accelerators Programme in last week's budget

/PRNewswire/ -- Todays FDA approval of the monoclonal antibody lecanemab (Leqembi) for the treatment of patients with early Alzheimers disease and confirmed...

/PRNewswire/ -- Todays FDA approval of the monoclonal antibody lecanemab (Leqembi) for the treatment of patients with early Alzheimers disease and confirmed...

Anti-amyloid therapy lecanemab is the first of many drugs needed to give patients meaningful relief from Alzheimers diseaseDeveloping new and nov...

Lecanemab, an amyloid-clearing monoclonal antibody drug shows positive results in the treatment of Alzheimer's disease. The drug is now poised for FDA approval early in 2023. Lecanemab slows cognitive decline by 27%.

/PRNewswire/ -- Target ALS and the Alzheimers Drug Discovery Foundation (ADDF) announced today the first four award recipients in a new initiative to identify...

Innovative Partnership Funds Research into Diagnostic Tools for Alzheimers Disease, ALS and Other Neurodegenerative DiseasesNEW YORK, Aug. 30, 20...

Bill Gates is one of the wealthiest people on the planet, but he said Wednesday he'll one day slip off that list. Here's how he spends his billions.

Bill Gates is one of the wealthiest people on the planet, but he said Wednesday he'll one day slip off that list. Here's how he spends his billions.

/PRNewswire/ -- Molecular Stethoscope, a leading precision medicine company pioneering the next-generation cell-free mRNA (cf-mRNA) liquid biopsy, announced...